UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.905-911

2016

Volltextzugriff (PDF)

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

Gut, 2008-04, Vol.57 (4), p.516-523

2008

Volltextzugriff (PDF)

Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease

The Journal of neuroscience, 2006-06, Vol.26 (23), p.6377-6385

2006

Volltextzugriff (PDF)

Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4

Gut, 2009-12, Vol.58 (12), p.1662-1669

2009

Volltextzugriff (PDF)

IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients

Journal of viral hepatitis, 2014-07, Vol.21 (7), p.525-532

2014

Volltextzugriff (PDF)

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

Gut, 2004-10, Vol.53 (10), p.1504-1508

2004

Volltextzugriff (PDF)

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients

Journal of viral hepatitis, 2011-08, Vol.18 (8), p.580-586

2011

Volltextzugriff (PDF)

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

Gut, 2003-11, Vol.52 (11), p.1638-1643

2003

Volltextzugriff (PDF)

The Power to Choose: Supports for Families Caring for Individuals with Developmental Disabilities

Health & social work, 2000-02, Vol.25 (1), p.59-68

2000

Volltextzugriff (PDF)

Nationwide HIV prevalence survey in general population in Niger

Tropical medicine & international health, 2004-11, Vol.9 (11), p.1161-1166

2004

Volltextzugriff (PDF)

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

JAMA : the journal of the American Medical Association, 2015-05, Vol.313 (17), p.1728

2015

Volltextzugriff (PDF)

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

Journal of viral hepatitis, 2005-07, Vol.12 (4), p.421-428

2005

Volltextzugriff (PDF)

Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C

Journal of viral hepatitis, 2006-10, Vol.13 (10), p.701-707

2006

Volltextzugriff (PDF)

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1195-1206

2011

Volltextzugriff (PDF)

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

The New England journal of medicine, 2011-03, Vol.364 (13), p.1207-1217

2011

Volltextzugriff (PDF)

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

The New England journal of medicine, 2003-02, Vol.348 (9), p.808-816

2003

Volltextzugriff (PDF)

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

Journal of hepatology, 2002-04, Vol.36 (4), p.543-546

2002

Volltextzugriff (PDF)

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

Antiviral therapy, 2009-01, Vol.14 (4), p.501-511

2009

Volltextzugriff (PDF)

Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C

Annals of internal medicine, 1996-09, Vol.125 (6), p.521

1996

Volltextzugriff (PDF)

Prospective study on anti-hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA

Hepatology (Baltimore, Md.), 2001-11, Vol.34 (5), p.1000-1005

2001

Volltextzugriff (PDF)

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

Hepatology (Baltimore, Md.), 1995-10, Vol.22 (4), p.1050-1056

1995

Volltextzugriff (PDF)

Retreatment with interferon-α of chronic hepatitis C virus infection

The Lancet (British edition), 1994-09, Vol.344 (8923), p.690-691

1994

Volltextzugriff (PDF)

Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine

Gut, 1993, Vol.34 (2), p.S106-S106

1993

Volltextzugriff (PDF)

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort

European journal of gastroenterology & hepatology, 2010-02, Vol.22 (2), p.157-166

2010

Volltextzugriff (PDF)

Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C

Clinical pharmacokinetics, 2005-01, Vol.44 (4), p.417-428

2005

Volltextzugriff (PDF)

1 – 25 von 380

Suche als RSS-Feed

Aktive Filter

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(306)
Mit Volltextzugriff
(252)

Publikationsform

Artikel
(378)
magazinearticle
(2)

Sprache

Englisch
(288)
Französisch
(92)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Baseline HBsAg and HBcrAg titres allow peginterferon-based 'precision medicine' in HBeAg-negative chronic hepatitis B patients

Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C

Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer's disease

Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4

IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients

Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy

Sequential therapy with adefovir dipivoxil and pegylated Interferon Alfa-2a for HBeAg-negative patients

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

The Power to Choose: Supports for Families Caring for Individuals with Developmental Disabilities

Nationwide HIV prevalence survey in general population in Niger

Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection

Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis

Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Positive Chronic Hepatitis B

Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers

Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin

Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C

Prospective study on anti-hepatitis C virus–positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA

Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C

Retreatment with interferon-α of chronic hepatitis C virus infection

Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine

Acute hepatitis C: analysis of a 126-case prospective, multicenter cohort

Pharmacokinetic/pharmacodynamic and time-to-event models of ribavirin-induced anaemia in chronic hepatitis C

Aktive Filter

Suchergebnisse filtern